Effect of budesonide/formoterol on severe exacerbations and lung function in moderate to severe COPD

被引：0
|
作者：
Calverley, PMA [1 ]
机构：
[1] Univ Hosp Aintree, Liverpool, Merseyside, England
来源：
THORAX | 2002年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S145
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Budesonide/formoterol in a single inhaler (Symbicort®) reduces severe exacerbations in patients with moderate to severe COPD
    Campbell, LM
    Szafranski, W
    THORAX, 2002, 57
  • [2] Early Efficacy Of Budesonide/formoterol In Patients With Moderate, Severe, And Very Severe COPD
    Similowski, T.
    Eriksson, G.
    Postma, D.
    Jenkins, C. R.
    Anzueto, A.
    Make, B. J.
    Fageras, M.
    Persson, A.
    Calverley, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [3] Budesonide/formoterol in a single inhaler (Symbicort®) provides early and sustained improvement in lung function in moderate to severe COPD
    Anderson, P
    THORAX, 2002, 57
  • [4] Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
    Calverley, Peter M.
    Eriksson, Goran
    Jenkins, Christine R.
    Anzueto, Antonio R.
    Make, Barry J.
    Persson, Anders
    Fageras, Malin
    Postma, Dirkje S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 13 - 25
  • [5] Impact of moderate and severe exacerbations in severe COPD patients
    Gunsoy, Necdet B.
    Pascoe, Katie
    Asukai, Yumi
    Gait, Claire
    Galkin, Dmitry
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [6] Effect of Budesonide/Formoterol Pressurized Metered-Dose Inhaler (pMDI) on Exacerbations in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
    Rennard, S. I.
    Tashkin, D. P.
    Martin, P.
    Goldman, M.
    Martin, U. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD
    Derom, Eric
    Strandgarden, Kerstin
    Schelfhout, Vanessa
    Borgstrom, Lars
    Pauwels, Romain
    RESPIRATORY MEDICINE, 2007, 101 (09) : 1931 - 1941
  • [8] Efficacy of Perforomist (Formoterol Fumarate) Inhalation Solution in Improving Lung Function in Moderate to Severe COPD
    Hanania, Nicola
    Sethi, Sanjay
    Koltun, Arkady
    Ward, Jon
    Spanton, Jacqui
    Ng, Dik
    CHEST, 2017, 152 (04) : 769A - 769A
  • [9] Budesonide/Formoterol Added to Tiotropium Is Well Tolerated and Reduces Risk of Severe Exacerbations in COPD Patients.
    Welte, T.
    Hartman, L.
    Polanowski, T.
    Hernandez, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [10] Budesonide/formoterol vs formoterol, both via Turbuhaler®, in patients with moderate to severe COPD: Phase III study results
    Ichinose, Masakazu
    Samoro, Ronnie
    Fassakhov, Rustem
    Oguri, Mitsuru
    Ekelund, Jan
    Carlsson, Lars-Goran
    Fukuchi, Yoshinosuke
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345